Gastroesophageal Reflux Disease (GERD) Device Market Size, Share, Device Type (Anti-Reflux Surgery Devices, Endoscopic Devices, Drug Delivery Devices Surgery, Monitoring Devices, and Others), Application (Treatment, Diagnostics, and Monitoring), End-User (Hospitals, Ambulatory Surgery Centers, and Others), and Region - Trends, Analysis, and Forecast Till 2034

• The gastroesophageal reflux disease (GERD) device market size is expected to be USD 6.52 Billion by 2034.
• The market was valued at USD 5.53 Billion in 2024.
• The market is growing at a CAGR of 1.8% during the forecast period.

Gastroesophageal Reflux Disease devices are medical instruments designed to cure chronic acid reflux by attacking the very roots of this disease. These instruments strengthen the lower esophageal sphincter- a muscular ring located at the bottom of the esophagus, which guards against the backward flow of stomach contents. In patients with GERD, this sphincter is either weak or defective and thus promotes frequent reflux episodes. Surging prevalence of GERD is expected to propel market expansion during the forecast period.

Key Takeaways:

• North America presently holds the largest GERD devices market share, owing to most cases being contributed by the U.S. and Canada. 
• Asia Pacific is registering a fast growth rate due to increasing awareness about GERD, better access to healthcare, and the growth of lifestyle diseases.

Rising Prevalence of GERD Aids Market Expansion

• The increasing prevalence of the disease due to lifestyle factors such as obesity, unhealthy diet, and stress will create opportunities for new effective treatment options. It, therefore, encourages demand for GERD devices, presenting alternatives to traditional management.

Technological Advancements to Augment Market Expansion

• This includes the technological advancement of innovative GERD devices, such as minimally invasive surgical options and advanced endoscopic procedures. These technical advances improve patient outcomes by reducing recovery time and enhancing the quality of life.

Growing Awareness and Acceptance to Boost Market Growth

• Awareness and acceptance are improving as patients and medical professionals become more aware of the condition. Thus, increasing awareness about the condition has motivated people suffering from GERD to adopt advanced devices that may help them manage their symptoms.

Restraints:

High Costs Can Impede Market Expansion

• The acquisition costs of the GERD device are high, though implementation costs are almost the same for every individual. All this means the high cost of treatment creates a big hurdle in market growth, especially in those areas where healthcare resources could be better. Further, continuous maintenance and monitoring of these devices increase the overall cost burden on patients and healthcare facilities. Insurance coverage for GERD devices is also limited, as many require significant out-of-pocket expenses. These can discourage patients from opting for advanced treatment options, even if it is beneficial for them.

Opportunities:

Emerging Markets to Provide Better Opportunities in the Future

• The middle-class population in emerging countries, such as India, China, and Brazil provides huge scope for the growth of the device market in GERD. Increased disposable income spending due to growing healthcare infrastructure will see a surge in demand for advanced medical treatments, such as GERD devices. This trend is more pronounced in urban areas as the population becomes wealthier and more health-conscious. Moreover, the increase in lifestyle-oriented diseases, including obesity and diabetes, acting as risk factors for GERD, further propels the demand for effective treatment modalities.

Device type, application, end-user, and region are the segments in which the gastroesophageal reflux disease (GERD) device market is divided.

Device Type Insights:

By device type, the market is classified into anti-reflux surgery devices, endoscopic devices, drug delivery devices surgery, monitoring devices, and others. The anti-reflux surgery devices segment is expected to dominate the market during the forecast period. The wide use of these devices in surgical procedures, such as fundoplication, boost the segment growth in the market.

Application Insights:

By application, the market is classified into treatment, diagnostics, and monitoring. The treatment segment is expected to lead the market during the forecast period owing to the high demand for minimally invasive and highly effective treatment options available globally.

End-User Insights:

On the basis of end-user, the market is classified into hospitals, ambulatory surgery centers, and others. The hospitals segment holds the largest gastroesophageal reflux disease (GERD) device market share as they consume the highest number of GERD devices due to the presence of modern facilities for diagnostic, surgical, and monitoring procedures.

Regional Insights:

Geographically, the market is studied across North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

• North America: North America presently holds the largest GERD devices market share, owing to most cases being contributed by the U.S. and Canada. This could be attributed to a high prevalence rate of GERD along with strong healthcare infrastructure and rising awareness regarding available treatment options. Moreover, technological development and high healthcare expenditure will further enable market growth in this region.
• Asia Pacific: The market is registering a fast growth rate due to increasing awareness about GERD, better access to healthcare, and the growth of lifestyle diseases. In addition to these factors, this region is also showing growth due to the rise in medical tourism and an increase in the number of investors who invest in improving healthcare infrastructure.

Gastroesophageal Reflux Disease (GERD) Device Market Report Scope:

Segmentation:

By Device Type:

• Anti-Reflux Surgery Devices
• Endoscopic Devices
• Drug Delivery Devices Surgery
• Monitoring Devices
• Others

By Application:

• Treatment
• Diagnostics
• Monitoring

By End-User:

• Hospitals
• Ambulatory Surgery Centers
• Others

By Region:

North America

• U.S.
• Canada

Europe

• Germany
• U.K.
• France
• Russia
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• Israel
• South Africa
• Rest of Middle East & Africa

The key players operating the gastroesophageal reflux disease gerd device market are Medtronic PLC, Boston Scientific Corporation, and others. These major market players are adopting strategies, such as new product launches and partnerships and collaborations to their dominance in the market.

List of Key Players in the Market:

• Medtronic PLC
• Johnson & Johnson Services, Inc.
• Boston Scientific Corporation
• EndoStim, Inc.
• Olympus Corporation
• Laborie Medical Technologies
• Medigus Ltd.
• Mederi Therapeutics Inc.
• Ethicon, Inc. (A subsidiary of Johnson & Johnson)
• Torax Medical, Inc. (Acquired by Medtronic)
• Koninklijke Philips N.V.
• Cook Medical Inc.
• Diversatek Healthcare Inc.
• C2 Therapeutics
• FUJIFILM Holdings Corporation

• In August 2024, Medtronic announced the launch of its new Linx Reflux Management System, an advanced anti-reflux surgery device. The system incorporates enhanced magnetic ring technology to improve durability and patient outcomes. This launch reflects Medtronic's commitment to advancing minimally invasive GERD treatments and addressing unmet needs in chronic reflux management.
• In July 2024, Boston Scientific introduced an upgraded version of its Endoscopic Suture System, which enhances the precision and efficiency of endoscopic anti-reflux procedures. The new system features a streamlined delivery mechanism and improved suture materials to reduce procedure times and enhance patient comfort.
• In June 2024, Johnson & Johnson announced a strategic partnership with EndoStim to co-develop next-generation neuromodulation therapies for GERD. This collaboration integrates EndoStim’s neurostimulation technology with Johnson & Johnson’s surgical expertise to offer more effective treatment options for severe GERD cases.

More Related Reports

Foot and Mouth Disease Vaccine Market
Liver Disease Diagnostics Market
Rare disease Market
Implantable Drug Device Market
Stuttering Device Market